US Futures Drop Ahead Of Payrolls With Most Markets Closed US equity futures dipped ahead of today's payrolls report in a holiday-shortened session, with most cash markets including US stocks closed globally for Good Friday. Sifma, the US financial markets trade association, recommended trading of dollar-denominated bonds during US hours only and a 12pm New York time stop. As of 8:15am, S&P and Na...
US Futures Drop Ahead Of Payrolls With Most Markets Closed US equity futures dipped ahead of today's payrolls report in a holiday-shortened session, with most cash markets including US stocks closed globally for Good Friday. Sifma, the US financial markets trade association, recommended trading of dollar-denominated bonds during US hours only and a 12pm New York time stop. As of 8:15am, S&P and Nasdaq futures are down 0.2%. Bonds dipped modestly in a holiday-shortened session, the 10Y yield rising 1bp to 4.31%. The dollar was mixed against its Group-of-10 peers. Oil rallied above $110 a barrel Thursday after Trump issued fresh threats against Iranian infrastructure in an effort to pressure Tehran in negotiations. West Texas Intermediate surged 11%, while the global Brent benchmark settled near $109. The jobs report is the main event on today's calendar and is due at 8:30am (preview below). Iran targeted more sites in Arab Gulf states overnight and into Friday. A container ship signaling French ownership exited the Strait of Hormuz, in what appeared to be the first known transit by a vessel linked to Western Europe since the Iran war all but shuttered the vital waterway. The main highlight today is the March jobs report ( full preview here ) which is expected to show a sharp rebound from February weather - and strike -related weakness, with a median forecast for nonfarm payrolls change of 65k; Bloomberg Economics anticipates a 150k rebound With most of Europe closed for Good Friday, Asian stocks were the only action overnight and rose at the end of another volatile week with a report leading to some optimism that more traffic may be allowed through the Strait of Hormuz. Regional shares followed a recovery in US equities Thursday on news that Iran is drafting a protocol with Oman to monitor traffic through the key waterway, having effectively shut it down since the start of the war. Trading was light in Asia with many key markets shut for holidays. MSCI’s benchmark As...
iQoncept/iStock via Getty Images Short sellers aggressively ramped up their positions in small-cap healthcare stocks as the first quarter concluded, driving a significant spike in bearish sentiment for companies with market capitalizations under $2 billion , according to March-end figures. Among the most shorted stocks, the 56.57% short interest in Sensei Biotherapeutics ( SNSE ) shows high pressu...
iQoncept/iStock via Getty Images Short sellers aggressively ramped up their positions in small-cap healthcare stocks as the first quarter concluded, driving a significant spike in bearish sentiment for companies with market capitalizations under $2 billion , according to March-end figures. Among the most shorted stocks, the 56.57% short interest in Sensei Biotherapeutics ( SNSE ) shows high pressure due to investor concerns over trial failures. In contrast, the least shorted names had short interest levels below 1%, indicating stability. Champions Oncology ( CSBR ), OKYO Pharma ( OKYO ), and SenesTech ( SNES ) all had 0.52% short interest, while Syra Health ( SYRA ) and Sol-Gel Technologies ( SLGL ) had 0.54% and 0.56%, respectively. Healthcare stocks are trailing the broader market so far this year. While the S&P 500 has struggled with a 3.95% decline year-to-date, the Health Care Select Sector SPDR® Fund ( XLV )—which represents roughly 12.1% of the benchmark index—has declined 5.07%. Here are the five most shorted healthcare stocks with market capitalizations of up to $2 billion (as a % of shares outstanding) as of March 31: Sensei Biotherapeutics ( SNSE ) – Biotechnology sector, short interest 56.57% Agape ATP Corporation ( ATPC ) - Health Care Distributors sector, short interest 46.29% KalVista Pharmaceuticals ( KALV ) – Biotechnology sector, short interest 37.93% 60 Degrees Pharmaceuticals ( SXTP ) – Pharmaceuticals sector, short interest 37.66% Acurx Pharmaceuticals ( ACXP ) – Biotechnology sector, short interest 36.63% Here are the five least shorted healthcare stocks with market capitalizations of up to $2 billion (as a % of shares outstanding) as of March 31: Champions Oncology ( CSBR ) Life Sciences Tools and Services sector, short interest 0.52% OKYO Pharma ( OKYO ) – Biotechnology sector, short interest 0.52% SenesTech ( SNES ) – Pharmaceuticals sector, short interest 0.52% Syra Health ( SYRA ) - Health Care Services sector, short interest 0.54% Sol-Gel...
Poland’s leading figurative artist de-faces Trump, feminist art rebels squat in East Sussex, and the UK’s street art is captured – all in your weekly dispatch Wilhelm Sasnal: family/history The domestic meets the political in these unsettling new paintings of family life and global current affairs (including some greyed-out visions of the Oval Office) by Poland’s leading figurative artist. • Sadie...
Poland’s leading figurative artist de-faces Trump, feminist art rebels squat in East Sussex, and the UK’s street art is captured – all in your weekly dispatch Wilhelm Sasnal: family/history The domestic meets the political in these unsettling new paintings of family life and global current affairs (including some greyed-out visions of the Oval Office) by Poland’s leading figurative artist. • Sadie Coles HQ , London, until 23 May Continue reading...
onurdongel/iStock via Getty Images Seritage Growth Properties ( SRG )( SRG.PR.A ) reported Q4 2025 results that showed relatively slow asset sale progress. Seritage closed on the sales of the three assets that it had under contract with no due diligence contingencies, but had only minor progress to report other than that. It had previously mentioned (in mid-November 2025 ) having other negotiation...
onurdongel/iStock via Getty Images Seritage Growth Properties ( SRG )( SRG.PR.A ) reported Q4 2025 results that showed relatively slow asset sale progress. Seritage closed on the sales of the three assets that it had under contract with no due diligence contingencies, but had only minor progress to report other than that. It had previously mentioned (in mid-November 2025 ) having other negotiations and contracts (with subjects) that could result in $118 million in additional gross proceeds, but currently only has 2026 contracts that are expected to $17 million in gross proceeds (including a sale that closed in Q1 2026). That limited sales progress over the last 4.5 months increases the chances of Seritage either receiving relatively weak prices for its remaining assets and/or taking longer to sell its assets than I previously expected. Thus I am reducing my estimate of Seritage's value from $4.00 per share to $3.25 per share and note that there is also higher uncertainly around that estimated value now. Slowing Asset Sale Progress In mid-November 2025, Seritage reported that it had three assets under contract with no due diligence contingencies for combined anticipated gross proceeds of $170 million. These sales closed in Q4 2025. Seritage also mentioned at that time that it had one asset under contract for $70.8 million, subject to a long dated closing and the pursuit of a master plan amendment. It also mentioned that it was negotiating definitive purchase and sale agreements on three joint venture assets that would result in combined anticipated gross distributions of around $47.3 million. Seritage indicated that it received a distribution of $5.7 million in Q1 2026 from an unconsolidated entity due to the sale of a portion of the underlying property. It also noted that at the end of Q1 2026, it had one joint venture asset under contract for anticipated proceeds of $11 million. Seritage didn't mention that the $70.8 million asset is still under contract, which may...
PennantPark ( PFLT ) declares $0.1025/share monthly dividend , in line with previous. Forward yield 15.0% Payable May 1; for shareholders of record April 15; ex-div April 15. See PFLT Dividend Scorecard, Yield Chart, & Dividend Growth. More on PennantPark PennantPark Floating Rate Capital: Newly Issued Bond Outshines The Common Stock PennantPark Floating Rate Capital: 15% Yield, 23% Discount, But ...
PennantPark ( PFLT ) declares $0.1025/share monthly dividend , in line with previous. Forward yield 15.0% Payable May 1; for shareholders of record April 15; ex-div April 15. See PFLT Dividend Scorecard, Yield Chart, & Dividend Growth. More on PennantPark PennantPark Floating Rate Capital: Newly Issued Bond Outshines The Common Stock PennantPark Floating Rate Capital: 15% Yield, 23% Discount, But A Clear No-Go Good Income From PennantPark Floating Rate Capital PennantPark prices $200 million 6.75% notes due 2029 PennantPark projects PSSL 2 JV to scale to $1B in assets, supporting dividend coverage